SEQENS CDMO
Major Drugs - Écully, Auvergne-R, US
SEQENS CDMO Details
Emergence of a new global CDMOThree custom development and manufacturing organizations – PCAS S.A. in France, Chemie Uetikon in Germany and PCI Synthesis in the United States – have joined forces as Seqens CDMO (formerly Novacap) to offer world-class Drug Substance Development and Manufacturing services to the pharmaceutical industry.With three R&D centers, six cGMP / FDA inspected production sites in Europe and the United States supported by two manufacturing sites for the production of critical intermediates and Regulatory Starting Materials (RSMs), the group offers a powerful manufacturing network employing approximately 1200 persons capable to embrace complexity in developing, industrializing and manufacturing complex molecular entities.
SEQENS CDMO Technologies
Email Providers
Outlook
Load Balancers
Varnish
CMS
WordPress.org
Fonts
Google Font API
Other
Microsoft Office 365
Analytics and Tracking
Google Analytics